Singapore markets close in 3 hours 44 minutes
Straits Times Index
3,344.18 +13.37 (+0.40%) Nikkei
38,621.14 -82.37 (-0.21%) Hang Seng
18,403.67 -73.13 (-0.40%) FTSE 100
8,285.34 +38.39 (+0.47%) Bitcoin USD
71,164.66 +245.33 (+0.35%) CMC Crypto 200
1,484.30 -40.50 (-2.66%)
Wilmar International Limited (RTHA.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 03:29PM CEST
| Previous close | 2.1140 |
| Open | 2.0870 |
| Bid | 2.0940 x 559600 |
| Ask | 2.1550 x 543600 |
| Day's range | 2.0870 - 2.0910 |
| 52-week range | 2.0830 - 2.7820 |
| Volume | |
| Avg. volume | 1,171 |
| Market cap | 13.104B |
| Beta (5Y monthly) | 0.49 |
| PE ratio (TTM) | 9.50 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.12 (5.50%) |
| Ex-dividend date | 29 Apr 2024 |
| 1y target est | N/A |
- PR Newswire
Cerecin forges strategic partnership with A*STAR's Institute of Molecular and Cell Biology (IMCB) in Singapore to advance R&D in neurological disorders.
Cerecin Inc., a clinical-stage biotechnology company at the forefront of developing innovative neurotherapeutics, is pleased to announce the establishment of a Memorandum of Understanding (MOU) with A*STAR's Institute of Molecular and Cell Biology (IMCB). This collaboration aims to accelerate research and treatment initiatives for neurological disorders and diseases to enhance overall health and brain function.
© 2024 Yahoo. All rights reserved.